{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:56:51Z","timestamp":1791356211821,"version":"4.3.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T00:00:00Z","timestamp":1282262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12026-010-8162-1","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T21:43:28Z","timestamp":1282254208000},"page":"3-13","source":"Crossref","is-referenced-by-count":23,"title":["Translating insights from persistent LCMV infection into anti-HIV immunity"],"prefix":"10.1007","volume":"48","author":[{"given":"Elizabeth B.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,20]]},"reference":[{"key":"8162_CR1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM198112103052401","volume":"305","author":"MS Gottlieb","year":"1981","unstructured":"Gottlieb MS, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305:1425\u201331.","journal-title":"N Engl J Med"},{"key":"8162_CR2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","volume":"220","author":"F Barre-Sinoussi","year":"1983","unstructured":"Barre-Sinoussi F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868\u201371.","journal-title":"Science"},{"key":"8162_CR3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.6601823","volume":"220","author":"RC Gallo","year":"1983","unstructured":"Gallo RC, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science. 1983;220:865\u20137.","journal-title":"Science"},{"key":"8162_CR4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.virol.2009.10.045","volume":"397","author":"L Montagnier","year":"2010","unstructured":"Montagnier L. 25\u00a0years after HIV discovery: prospects for cure and vaccine. Virology. 2010;397:248\u201354.","journal-title":"Virology"},{"key":"8162_CR5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","volume":"191","author":"NM Flynn","year":"2005","unstructured":"Flynn NM, Forthal DN, Harro CD, Judson FN, Mayer KH, Para MF. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis. 2005;191:654\u201365.","journal-title":"J Infect Dis"},{"key":"8162_CR6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1086\/587993","volume":"46","author":"FH Priddy","year":"2008","unstructured":"Priddy FH, et al. Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag\/pol\/nef vaccine in healthy adults. Clin Infect Dis. 2008;46:1769\u201381.","journal-title":"Clin Infect Dis"},{"key":"8162_CR7","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","volume":"194","author":"P Pitisuttithum","year":"2006","unstructured":"Pitisuttithum P, et al. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis. 2006;194:1661\u201371.","journal-title":"J Infect Dis"},{"key":"8162_CR8","first-page":"1","volume":"263","author":"RM Zinkernagel","year":"2002","unstructured":"Zinkernagel RM. Lymphocytic choriomeningitis virus and immunology. Curr Top Microbiol Immunol. 2002;263:1\u20135.","journal-title":"Curr Top Microbiol Immunol"},{"key":"8162_CR9","unstructured":"Borrow P, Oldstone MB. Lymphocytic choriomeningitis virus. In: Nathanson N, editor. Viral Pathogenesis. Philadelphia: Lippincott-Raven; 1997. p. 593\u2013627."},{"key":"8162_CR10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni1241","volume":"6","author":"P Klenerman","year":"2005","unstructured":"Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol. 2005;6:873\u20139.","journal-title":"Nat Immunol"},{"key":"8162_CR11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.160.2.521","volume":"160","author":"R Ahmed","year":"1984","unstructured":"Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med. 1984;160:521\u201340.","journal-title":"J Exp Med"},{"key":"8162_CR12","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1128\/JVI.79.16.10514-10527.2005","volume":"79","author":"DG Brooks","year":"2005","unstructured":"Brooks DG, Teyton L, Oldstone MB, McGavern DB. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J Virol. 2005;79:10514\u201327.","journal-title":"J Virol"},{"key":"8162_CR13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","volume":"187","author":"A Gallimore","year":"1998","unstructured":"Gallimore A, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med. 1998;187:1383\u201393.","journal-title":"J Exp Med"},{"key":"8162_CR14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry EJ, et al. Molecular signature of CD8 T cell exhaustion during chronic viral infection. Immunity. 2007;27:670\u201384.","journal-title":"Immunity"},{"key":"8162_CR15","doi-asserted-by":"crossref","unstructured":"Zajac AJ et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998;188: 2205\u201313.","DOI":"10.1084\/jem.188.12.2205"},{"key":"8162_CR16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","volume":"4","author":"EJ Wherry","year":"2003","unstructured":"Wherry EJ, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol. 2003;4:225\u201334.","journal-title":"Nat Immunol."},{"key":"8162_CR17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/eji.200940102","volume":"40","author":"H Frebel","year":"2010","unstructured":"Frebel H, Richter K, Oxenius A. How chronic viral infections impact on antigen-specific T-cell responses. Eur J Immunol. 2010;40:654\u201363.","journal-title":"Eur J Immunol"},{"key":"8162_CR18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.coi.2010.03.004","volume":"22","author":"LM Fahey","year":"2010","unstructured":"Fahey LM, Brooks DG. Opposing positive and negative regulation of T cell activity during viral persistence. Curr Opin Immunol. 2010;22:348\u201354.","journal-title":"Curr Opin Immunol"},{"key":"8162_CR19","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1128\/JVI.01388-06","volume":"81","author":"M Lichterfeld","year":"2007","unstructured":"Lichterfeld M, et al. Selective depletion of high-avidity human immunodeficiency virus type 1 (H IV1)-specific CD8 T cells after early HIV-1 infection. J Virol. 2007;81:4199\u2013214.","journal-title":"J Virol"},{"key":"8162_CR20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","volume":"10","author":"AJ McMichael","year":"2010","unstructured":"McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol. 2010;10:11\u201323.","journal-title":"Nat Rev Immunol"},{"key":"8162_CR21","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1172\/JCI26856","volume":"116","author":"DG Brooks","year":"2006","unstructured":"Brooks DG, McGavern DB, Oldstone MB. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest. 2006;116:1675\u201385.","journal-title":"J Clin Invest"},{"key":"8162_CR22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","volume":"206","author":"N Goonetilleke","year":"2009","unstructured":"Goonetilleke N, et al. The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med. 2009;206:1253\u201372.","journal-title":"J Exp Med"},{"key":"8162_CR23","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1128\/JVI.00182-09","volume":"83","author":"H Streeck","year":"2009","unstructured":"Streeck H, et al. Human immunodeficiency virus type 1-specific CD8 T-cell responses during primary infection are major determinants of the viral set point and loss of CD4 T cells. J Virol. 2009;83:7641\u20138.","journal-title":"J Virol"},{"key":"8162_CR24","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.4049\/jimmunol.0803658","volume":"182","author":"EL Turnbull","year":"2009","unstructured":"Turnbull EL, et al. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection. J Immunol. 2009;182:7131\u201345.","journal-title":"J Immunol"},{"key":"8162_CR25","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1168676","volume":"323","author":"Q Li","year":"2009","unstructured":"Li Q, et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science. 2009;323:1726\u20139.","journal-title":"Science."},{"key":"8162_CR26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber DL, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439:682\u20137.","journal-title":"Nature."},{"key":"8162_CR27","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","volume":"12","author":"DG Brooks","year":"2006","unstructured":"Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006;12:1301\u20139.","journal-title":"Nat Med"},{"key":"8162_CR28","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","volume":"203","author":"M Ejrnaes","year":"2006","unstructured":"Ejrnaes M, et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med. 2006;203:2461\u201372.","journal-title":"J Exp Med"},{"key":"8162_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn SD, et al. Coregulation of CD8 T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 2009;10:29\u201337.","journal-title":"Nat Immunol."},{"key":"8162_CR30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2009.06.015","volume":"31","author":"R Tinoco","year":"2009","unstructured":"Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8 T cell deletion and viral persistence in vivo. Immunity. 2009;31:145\u201357.","journal-title":"Immunity"},{"key":"8162_CR31","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","volume":"11","author":"Y Ishida","year":"1992","unstructured":"Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11:3887\u201395.","journal-title":"EMBO J"},{"key":"8162_CR32","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1073\/pnas.0801497105","volume":"105","author":"SD Blackburn","year":"2008","unstructured":"Blackburn SD, Shin H, Freeman GJ, Wherry EJ. Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade. Proc Natl Acad Sci USA. 2008;105:15016\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8162_CR33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day CL, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350\u20134.","journal-title":"Nature"},{"key":"8162_CR34","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1084\/jem.20061496","volume":"203","author":"C Petrovas","year":"2006","unstructured":"Petrovas C, et al. PD-1 is a regulator of virus-specific CD8 T cell survival in HIV infection. J Exp Med. 2006;203:2281\u201392.","journal-title":"J Exp Med"},{"key":"8162_CR35","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","volume":"12","author":"L Trautmann","year":"2006","unstructured":"Trautmann L, et al. Upregulation of PD-1 expression on HIV-specific CD8 T cells leads to reversible immune dysfunction. Nat Med. 2006;12:1198\u2013202.","journal-title":"Nat Med"},{"key":"8162_CR36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature07662","volume":"458","author":"V Velu","year":"2008","unstructured":"Velu V, et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature. 2008;458:206\u201310.","journal-title":"Nature"},{"key":"8162_CR37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2106","volume":"16","author":"EA Said","year":"2010","unstructured":"Said EA, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4 T cell activation during HIV infection. Nat Med. 2010;16:452\u20139.","journal-title":"Nat Med"},{"key":"8162_CR38","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","volume":"170","author":"DF Fiorentino","year":"1989","unstructured":"Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081\u201395.","journal-title":"J Exp Med"},{"key":"8162_CR39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O\u2019Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683\u2013765.","journal-title":"Annu Rev Immunol"},{"key":"8162_CR40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(06)70577-1","volume":"6","author":"JL Mege","year":"2006","unstructured":"Mege JL, Meghari S, Honstettre A, Capo C, Raoult D. The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis. 2006;6:557\u201369.","journal-title":"Lancet Infect Dis"},{"key":"8162_CR41","doi-asserted-by":"crossref","first-page":"20428","DOI":"10.1073\/pnas.0811139106","volume":"105","author":"DG Brooks","year":"2008","unstructured":"Brooks DG, Ha SJ, Elsaesser H, Sharpe AH, Freeman GJ, Oldstone MB. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc Natl Acad Sci USA. 2008;105:20428\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8162_CR42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1084\/jem.20071948","volume":"205","author":"DG Brooks","year":"2008","unstructured":"Brooks DG, Lee AM, Elsaesser H, McGavern DB, Oldstone MB. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med. 2008;205:533\u201341.","journal-title":"J Exp Med"},{"key":"8162_CR43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0463.2006.apm_108.x","volume":"114","author":"MA Orsilles","year":"2006","unstructured":"Orsilles MA, Pieri E, Cooke P, Caula C. IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy. Apmis. 2006;114:55\u201360.","journal-title":"Apmis"},{"key":"8162_CR44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2249.1999.00865.x","volume":"116","author":"E Stylianou","year":"1999","unstructured":"Stylianou E, Aukrust P, Kvale D, Muller F, Froland SS. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression\u2013down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol. 1999;116:115\u201320.","journal-title":"Clin Exp Immunol"},{"key":"8162_CR45","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI117031","volume":"93","author":"M Clerici","year":"1994","unstructured":"Clerici M, et al. Role of interleukin-1 0 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest. 1994;93:768\u201375.","journal-title":"J Clin Invest"},{"key":"8162_CR46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2008-12-191296","volume":"114","author":"MA Brockman","year":"2009","unstructured":"Brockman MA, et al. IL-10 is upregulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood. 2009;114:346\u201356.","journal-title":"Blood"},{"key":"8162_CR47","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/infdis\/173.5.1085","volume":"173","author":"AL Landay","year":"1996","unstructured":"Landay AL, Clerici M, Hashemi F, Kessler H, Berzofsky JA, Shearer GM. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. J Infect Dis. 1996;173:1085\u201391.","journal-title":"J Infect Dis"},{"key":"8162_CR48","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1097\/QAD.0b013e328331a424","volume":"23","author":"H Yang","year":"2009","unstructured":"Yang H, et al. Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption. AIDS. 2009;23:2226\u201330.","journal-title":"AIDS"},{"key":"8162_CR49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.coi.2005.04.004","volume":"17","author":"J Borst","year":"2005","unstructured":"Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005;17:275\u201381.","journal-title":"Curr Opin Immunol"},{"key":"8162_CR50","doi-asserted-by":"crossref","first-page":"13353","DOI":"10.1074\/jbc.273.21.13353","volume":"273","author":"H Akiba","year":"1998","unstructured":"Akiba H, et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NFkappaB and stress-activated protein kinase\/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB inducing kinase. J Biol Chem. 1998;273:13353\u20138.","journal-title":"J Biol Chem"},{"key":"8162_CR51","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1084\/jem.20060651","volume":"203","author":"M Matter","year":"2006","unstructured":"Matter M, Odermatt B, Yagita H, Nuoffer JM, Ochsenbein AF. Elimination of chronic viral infection by blocking CD27 signaling. J Exp Med. 2006;203:2145\u201355.","journal-title":"J Exp Med"},{"key":"8162_CR52","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1073\/pnas.040558797","volume":"97","author":"A Ciurea","year":"2000","unstructured":"Ciurea A, et al. Viral persistence in vivo through selection of neutralizing antibody-escape variants. Proc Natl Acad Sci USA. 2000;97:2749\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8162_CR53","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1086\/516508","volume":"176","author":"AK Pilgrim","year":"1997","unstructured":"Pilgrim AK, et al. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis. 1997;176:924\u201332.","journal-title":"J Infect Dis"},{"key":"8162_CR54","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","volume":"17","author":"MD Hazenberg","year":"2003","unstructured":"Hazenberg MD, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 2003;17:1881\u20138.","journal-title":"AIDS"},{"key":"8162_CR55","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/blood-2003-07-2375","volume":"103","author":"A Milito De","year":"2004","unstructured":"De Milito A, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood. 2004;103:2180\u20136.","journal-title":"Blood"},{"key":"8162_CR56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.iy.11.040193.001555","volume":"11","author":"DC Parker","year":"1993","unstructured":"Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331\u201360.","journal-title":"Annu Rev Immunol"},{"key":"8162_CR57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","volume":"300","author":"JC Sun","year":"2003","unstructured":"Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003;300:339\u201342.","journal-title":"Science"},{"key":"8162_CR58","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","volume":"421","author":"EM Janssen","year":"2003","unstructured":"Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD4 T cells are required for secondary expansion and memory in CD8 T lymphocytes. Nature. 2003;421:852\u20136.","journal-title":"Nature"},{"key":"8162_CR59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","volume":"300","author":"DJ Shedlock","year":"2003","unstructured":"Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300:337\u20139.","journal-title":"Science"},{"key":"8162_CR60","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4049\/jimmunol.170.3.1443","volume":"170","author":"H Shen","year":"2003","unstructured":"Shen H, Whitmire JK, Fan X, Shedlock DJ, Kaech SM, Ahmed R. A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J Immunol. 2003;170:1443\u201351.","journal-title":"J Immunol"},{"key":"8162_CR61","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.4049\/jimmunol.171.12.6339","volume":"171","author":"JC Wang","year":"2003","unstructured":"Wang JC, Livingstone AM. Cutting edge: CD4 T cell help can be essential for primary CD8 T cell responses in vivo. J Immunol. 2003;171:6339\u201343.","journal-title":"J Immunol"},{"key":"8162_CR62","first-page":"708","volume":"29","author":"BC Ho","year":"2000","unstructured":"Ho BC, Laudette-Aboulhab J, Se-Thoe SY, Chan SP, Ling AE, Leo YS. Correlation of baseline quantitative plasma human immunodeficiency (HIV) type 1 RNA viral load with clinical status and CD4 T-cell counts in treatment-naive HIV-positive patients in Singapore. Ann Acad Med Singapore. 2000;29:708\u201313.","journal-title":"Ann Acad Med Singapore"},{"key":"8162_CR63","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/JVI.68.12.8056-8063.1994","volume":"68","author":"M Matloubian","year":"1994","unstructured":"Matloubian M, Concepcion RJ, Ahmed R. CD4 T cells are required to sustain CD8 cytotoxic T-cell responses during chronic viral infection. J Virol. 1994;68:8056\u201363.","journal-title":"J Virol"},{"key":"8162_CR64","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1128\/JVI.68.7.4700-4704.1994","volume":"68","author":"M Battegay","year":"1994","unstructured":"Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, Zinkernagel RM. Enhanced establishment of a virus carrier state in adult CD4 T-cell-deficient mice. J Virol. 1994;68:4700\u20134.","journal-title":"J Virol"},{"key":"8162_CR65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12026-009-8102-0","volume":"45","author":"AM Livingstone","year":"2009","unstructured":"Livingstone AM, Wilson EB, Ontiveros F, Wang JC. Unravelling the mechanisms of help for CD8+\u00a0T cell responses. Immunol Res. 2009;45:209\u201317.","journal-title":"Immunol Res"},{"key":"8162_CR66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.immunol.25.022106.141548","volume":"25","author":"MA Williams","year":"2007","unstructured":"Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol. 2007;25:171\u201392.","journal-title":"Annu Rev Immunol"},{"key":"8162_CR67","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.121.6.2168","volume":"121","author":"PE Baker","year":"1978","unstructured":"Baker PE, Gillis S, Ferm MM, Smith KA. The effect of T cell growth factor on the generation of cytolytic T cells. J Immunol. 1978;121:2168\u201373.","journal-title":"J Immunol"},{"key":"8162_CR68","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1073\/pnas.77.10.6134","volume":"77","author":"JW Mier","year":"1980","unstructured":"Mier JW, Gallo RC. Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc Natl Acad Sci USA. 1980;77:6134\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8162_CR69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","volume":"32","author":"ME Pipkin","year":"2010","unstructured":"Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity. 2010;32:79\u201390.","journal-title":"Immunity"},{"key":"8162_CR70","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04790","volume":"441","author":"MA Williams","year":"2006","unstructured":"Williams MA, Tyznik AJ, Bevan MJ. Interleukin-2 signals during priming are required for secondary expansion of CD8 memory T cells. Nature. 2006;441:890\u20133.","journal-title":"Nature"},{"key":"8162_CR71","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.4049\/jimmunol.181.11.7445","volume":"181","author":"EB Wilson","year":"2008","unstructured":"Wilson EB, Livingstone AM. Cutting edge: CD4 T cell-derived IL-2 is essential for help-dependent primary CD8 T cell responses. J Immunol. 2008;181:7445\u20138.","journal-title":"J Immunol"},{"key":"8162_CR72","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/eji.200637023","volume":"37","author":"MF Bachmann","year":"2007","unstructured":"Bachmann MF, Wolint P, Walton S, Schwarz K, Oxenius A. Differential role of IL-2R signaling for CD8 T cell responses in acute and chronic viral infections. Eur J Immunol. 2007;37:1502\u201312.","journal-title":"Eur J Immunol"},{"key":"8162_CR73","first-page":"88","volume":"8","author":"F Aiuti","year":"2006","unstructured":"Aiuti F, Mezzaroma I. Failure to reconstitute CD4 T-cells despite suppression of HIV replication under HAART. AIDS Rev. 2006;8:88\u201397.","journal-title":"AIDS Rev"},{"key":"8162_CR74","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nm866","volume":"9","author":"JN Blattman","year":"2003","unstructured":"Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med. 2003;9:540\u20137.","journal-title":"Nat Med"},{"key":"8162_CR75","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2796.2010.02221.x","volume":"267","author":"ML Gougeon","year":"2010","unstructured":"Gougeon ML, Chiodi F. Impact of gamma-chain cytokines on T cell homeostasis in HIV-1 infection: therapeutic implications. J Intern Med. 2010;267:502\u201314.","journal-title":"J Intern Med"},{"key":"8162_CR76","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1086\/322804","volume":"184","author":"AE Sousa","year":"2001","unstructured":"Sousa AE, Chaves AF, Loureiro A, Victorino RM. Comparison of the frequency of interleukin (IL)- 2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J Infect Dis. 2001;184:552\u20139.","journal-title":"J Infect Dis"},{"key":"8162_CR77","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00002030-200403260-00005","volume":"18","author":"SE Gloster","year":"2004","unstructured":"Gloster SE, et al. Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection. AIDS. 2004;18:749\u201355.","journal-title":"AIDS"},{"key":"8162_CR78","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","volume":"278","author":"ES Rosenberg","year":"1997","unstructured":"Rosenberg ES, et al. Vigorous HIV-1-specific CD4 T cell responses associated with control of viremia. Science. 1997;278:1447\u201350.","journal-title":"Science"},{"key":"8162_CR79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","volume":"26","author":"R Spolski","year":"2008","unstructured":"Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 2008;26:57\u201379.","journal-title":"Annu Rev Immunol"},{"key":"8162_CR80","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1172815","volume":"324","author":"A Frohlich","year":"2009","unstructured":"Frohlich A, et al. IL-21 R on T cells is critical for sustained functionality and control of chronic viral infection. Science. 2009;324:1576\u201380.","journal-title":"Science"},{"key":"8162_CR81","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1174182","volume":"324","author":"H Elsaesser","year":"2009","unstructured":"Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science. 2009;324:1569\u201372.","journal-title":"Science"},{"key":"8162_CR82","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1126\/science.1175194","volume":"324","author":"JS Yi","year":"2009","unstructured":"Yi JS, Du M, Zajac AJ. A vital role for interleukin-21 in the control of a chronic viral infection. Science. 2009;324:1572\u20136.","journal-title":"Science"},{"key":"8162_CR83","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.0903915","volume":"185","author":"FY Yue","year":"2010","unstructured":"Yue FY, et al. HIV-specific IL-21 producing CD4(+) T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J Immunol. 2010;185:498\u2013506.","journal-title":"J Immunol"},{"key":"8162_CR84","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4049\/jimmunol.0901967","volume":"184","author":"A Iannello","year":"2010","unstructured":"Iannello A, et al. Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J Immunol. 2010;184:114\u201326.","journal-title":"J Immunol"},{"key":"8162_CR85","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1440-1746.2006.04304.x","volume":"21","author":"JY Cheong","year":"2006","unstructured":"Cheong JY, et al. Association between chronic hepatitis B virus infection and interleukin-1 0, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol. 2006;21:1163\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"8162_CR86","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/314883","volume":"180","author":"M Helminen","year":"1999","unstructured":"Helminen M, Lahdenpohja N, Hurme M. Polymorphism of the interleukin-1 0 gene is associated with susceptibility to Epstein-Barr virus infection. J Infect Dis. 1999;180:496\u20139.","journal-title":"J Infect Dis"},{"key":"8162_CR87","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1128\/JVI.00339-06","volume":"80","author":"N Paladino","year":"2006","unstructured":"Paladino N, et al. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J Virol. 2006;80:9144\u201350.","journal-title":"J Virol"},{"key":"8162_CR88","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/hmg\/ddg104","volume":"12","author":"HD Shin","year":"2003","unstructured":"Shin HD, et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet. 2003;12:901\u20136.","journal-title":"Hum Mol Genet"},{"key":"8162_CR89","doi-asserted-by":"crossref","first-page":"14467","DOI":"10.1073\/pnas.97.26.14467","volume":"97","author":"HD Shin","year":"2000","unstructured":"Shin HD, et al. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA. 2000;97:14467\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8162_CR90","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/CJI.0b013e3181dcd260","volume":"33","author":"SS Agarwala","year":"2010","unstructured":"Agarwala SS, Ribas A. Current experience with CTLA4-blocking monoclonal antibodies for the treatment of solid tumors. J Immunother. 2010;33:557\u201369.","journal-title":"J Immunother"},{"key":"8162_CR91","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1128\/JVI.01177-06","volume":"80","author":"S Urbani","year":"2006","unstructured":"Urbani S, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol. 2006;80:11398\u2013403.","journal-title":"J Virol"},{"key":"8162_CR92","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","volume":"81","author":"C Boni","year":"2007","unstructured":"Boni C, et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 2007;81:4215\u201325.","journal-title":"J Virol"},{"key":"8162_CR93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/intimm\/dxp107","volume":"22","author":"K Richter","year":"2010","unstructured":"Richter K, Agnellini P, Oxenius A. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection. Int Immunol. 2010;22:13\u201323.","journal-title":"Int Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-010-8162-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-010-8162-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-010-8162-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T22:45:35Z","timestamp":1685745935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-010-8162-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,20]]},"references-count":93,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["8162"],"URL":"https:\/\/doi.org\/10.1007\/s12026-010-8162-1","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,20]]}}}